What does the evidence say about Myo-Inositol Anxiety Randomized Trial?

The current Migaku evidence database contains 1 reusable source document for Myo-Inositol Anxiety Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Importance Female infertility affects approximately one in six couples worldwide and disproportionately impacts women aged 30-42 years, yet evidence on which interventions improve clinically meaningful outcomes (live birth and safety) is heterogeneous. [Barroso Alverde MJ (2026); evidence level 1] - Objective The aim of this study was to synthesize evidence on interventions that restore or improve fertility in women aged 30-42 years, grouped by etiology. [Barroso Alverde MJ (2026); evidence level 1] - Evidence review We conducted a PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses)-compliant systematic review (PROSPERO CRD420251109428). [Barroso Alverde MJ (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.